Sleep Disorders Trial, Recruiting NCT06474390 Sponsor: PranaQ Pte. Ltd. Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06474390
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 20 or older who have been scheduled for an overnight sleep study (called a PSG) at Duke University Hospital
  • People who are able to understand the study information and sign a consent form before joining
  • People who are willing to participate, with the freedom to leave the study at any time

Who may not be able to join:

  • People who have had a heart transplant
  • People with heart failure that is classified as severe (stage III or IV under a standard medical grading system)
  • People with severe chronic obstructive lung disease (COPD), classified as stage 3 or 4 under a standard medical grading system
  • People who regularly use opioid pain medications
  • People who have had a severe stroke with significant lasting disability, as measured by a standard medical scoring system (confirm with trial site for exact score threshold)
  • People who have a tracheostomy (a surgical opening in the throat used for breathing)
  • People who are unable to understand the study information or sign the consent forms — for example, those with advanced Alzheimer's disease, those who are unconscious due to a head injury, or those with significantly limited mental capacity
  • People who are unable to correctly follow the instructions for using a device called the TipTraQ

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886-2-77415277

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
PranaQ Pte. Ltd.
Registry
ClinicalTrials.gov
Start date
1 June 2024
Est. completion
31 May 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Oxygen Desaturation Index(ODI); Apnea Hypopnea Index(AHI); Total Sleep Time(TST)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov